Poster presentations from the 12th Workshop on Recent Issues in Bioanalysis (WRIB)

The 12th Workshop on Recent Issues in Bioanalysis (WRIB) was held from 10–12 April 2018 in Philadelphia, USA. The Bioanalysis and Bioanalysis Zone team were in attendance and had an exciting few days attending talks, viewing posters and networking with new and familiar faces. Find out more about the poster presentations and award winners below.

“We were very proud to be supporting the WRIB Outstanding Poster Awards once again. WRIB has always provided a platform for upcoming scientists to showcase their work and we are delighted to be playing a part in ensuring their vision for the future reaches the global bioanalytical community. Each year the quality of the presentations increase and this year was no different, so congratulations to all presenters. Three winners were announced and presented with their prizes at WRIB, and we very much look forward to working with them on the Special Feature. Congratulations once again to the winners: Andreas Gloge (Roche; Basel, Switzerland), Susan Zondlo (QPS; PA, USA) and Ashley Frazer-Abel (University of Colarado; CO, USA).”

Sankeetha Nadarajah, Managing Commissioning Editor, Bioanalysis.

Find out more about the three winners in the following exclusive interviews for Bioanalysis and Bioanalysis Zone.

Establishment of a Bioanalytical Strategy for a new Drug Candidate posing extreme Instability Issues

Andreas Gloge, Roche

Andreas Gloge is a Bioanalytical Manager in R&D Bioanalytics at F. Hoffmann-La Roche (Basel, Switzerland). After receiving his PhD in biochemistry from the University of Karlsruhe (Germany), he completed a post-doctoral fellowship at Novartis/Syngenta (Basel, Switzerland) and then joined Roche (Basel, Switzerland) as a Bioanalytical Laboratory Head. He has nearly 20 years of experience in the field of regulated bioanalysis supporting preclinical and clinical bioanalysis for small molecules.

Validation of a Polymerase Chain Reaction (RT-qPCR) Method to Quantify a Codon-optimized Human Cystic Fibrosis Transmembrane Conductance RegulatormRNA (CO-hCFTR)

Susan Zondlo, QPS

Susan Zondlo joined QPS, LLC (PA, USA) in 2008 and is currently serving as a Director of Bioanalysis in the Department of Translational Medicine. In this position, Susan serves as Manager of teams for gene and sequence analysis, protein LC–MS/MS and biomarkers. Prior to joining QPS, Susan held senior research scientist positions at Millennium Pharmaceuticals (MA, USA), Bristol-Myers Squibb (NJ, USA), and the University of Delaware (DE, USA), where she also served as an Adjunct Professor in the Department of Chemistry and Biochemistry. Susan received her BA in biology from Rice University (TX, USA) and her PhD in molecular, cellular and developmental biology from Yale University (CT, USA).

The effects of sub-optimal sample handling on multiple complement measurements: Is there a potential signature of mishandling?

Ashley Frazer-Abel, Exsera BioLabs (University of Colorado)

“To my work in complement immuno-biology, I brought my PhD in biochemistry and post docs in immunology. After initially working in clinical immunology, I expanded my focus to include work to support FDA IND enabling studies. At the time I started working in complement and non-clinical and clinical trials, most of the work we did was related to immuno-toxicology and the potential for adverse complement responses to the new biological classes of drugs. It is exciting to now be involved in testing for diagnosis and efficacy. My continued work in diagnostics has given me the opportunity to see patient lives change when a new drug is available for them and to know I played some part in getting that drug to market, safely.”